patent.fyi
Applications  /  US 2026/0355504
United States Patent Application Publication

US 2026/0355504 A1

Published
Nov 12, 2026
Filed
Jul 21, 2026
Earliest date on the face
Nov 28, 2022
Classification
A61N 1/0492
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Closed ring electrode carrier

What ifWhat if a continuous oval ring carried the electrodes?
Claim language“a first end and a second end”

A molded silicone ring surrounds the eye opening and carries a conductive contact on the inner face of its lower arc. The lower arc seats against the skin of the lower eyelid, and an embedded lead connects the contact to the pulse source.

1.1Electrode on the cornea

What ifWhat if a scleral lens held the stimulation electrode against the cornea?
Claim language“an outer surface of at least one of the upper eyelid”

A flexible conductive filament crosses the concave face of the lens and contacts the tear film over the cornea. An insulated lead connects the filament to a current source, and a skin electrode on the temple provides the return path.

1.1Heat from a resistive film

What ifWhat if a resistive film delivered heat to the closed eyelid?
Claim language“apply electrical-stimulation therapy to an eye of a patient”

A flexible resistive heater transfers heat through an electrically insulating silicone layer that rests on the lid. A thermistor measures the contact surface temperature, and a feedback circuit adjusts heater power to hold the setpoint.

1.2Frame with spring retention

What ifWhat if a headband and spring arm held the substrate against the eyelid?
Claim language“a plurality of adhesive pads”

An elastic headband holds a rigid support across the brow. A compliant spring arm extends from the support and presses the electrode substrate against the closed eyelid.

1.2Electrode beyond both pads

What ifWhat if both pads anchored the strip on the temple and the electrode sat beyond both pads on a free extension?
Claim language“between the first adhesive pad and the second adhesive pad”

Two adhesive pads anchor the strip along the temple, and a precurved polymer extension reaches from the inner pad to the lower eyelid. The extension flexes against the skin and holds the electrode face in contact.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Electrode fixture for bench testing

A conductive silicone insert shaped like a closed eyelid sits flush in a curved headform. Two adhesive pads fix a flexible electrode strip to the headform with the electrode contacts over the insert and between the pads. A stimulation controller drives the contacts while a differential probe records the voltage across a calibrated resistor in the fixture.

Component substitution

Conductive textile contacts on the strip

Silver-plated nylon fabric replaces the metal contact plates on a flexible polyurethane strip. Each fabric patch sits over the outer eyelid between the two adhesive pads and connects to a separate printed trace through a conductive adhesive joint. An insulating laminate covers the traces and joints and leaves the fabric contact surfaces exposed.

Repositionable silicone pads at attachment points

Soft silicone adhesive pads replace the acrylic pressure-sensitive pads on the flexible strip. One pad bonds to the underside at the first end and the second bonds at an intermediate point, with the eyelid contacts exposed between them. The silicone skin-facing surfaces hold the strip during stimulation and allow the pads to be lifted and reseated to align the contacts.

Parameter or scale variation

Four contacts at five millimeter pitch

A flexible strip carries four circular contacts, each 3 mm in diameter, on 5 mm centers along the outer surface of the lower eyelid. One adhesive pad sits at the first end of the strip and the other sits beyond the contact row, before the second end. Separate traces connect the four contacts to a controller that selects two adjacent contacts for each stimulation interval.

Combination with existing systems

Synchronization with a video eyelid recorder

Two adhesive pads anchor the strip with its contacts on the outer surface of the lower eyelid. A video eyelid recorder frames the eye from the front and receives an isolated trigger from the stimulation controller at the start of each pulse train. The recorder stores the trigger alongside the video frame timestamps and measures the interval from the trigger to the first frame showing lid movement.

Automated or data-driven variant

Automatic detection of poor electrode contact

Two independently wired contacts sit over the outer eyelid between the adhesive pads. Before each pulse train, the controller passes a low-amplitude alternating test current between the contacts and measures the resulting differential voltage. Firmware calculates the magnitude of the contact-pair impedance, compares it with configured limits, and inhibits the pulse train and displays a contact status indicator when the reading falls outside those limits.

Specific version of a part

Printed contacts on flexible film

A thermoplastic polyurethane strip carries two screen-printed silver chloride contacts aligned with the lower eyelid. Conductive hydrogel covers the contact faces, and an insulating overlayer covers the printed traces.

Silicone pads on fabric tabs

A fabric tab at the first end and a second tab at an intermediate position carry pressure-sensitive silicone adhesive. The exposed electrode section spans the gap between the tabs and rests against the eyelid.

Foam pads with acrylic adhesive

Die-cut polyethylene foam pads carry a skin-facing acrylic adhesive. One pad bonds to the first end of the substrate and the other bonds to an intermediate position, with the electrode contacts between them.

Timed biphasic current pulses

A microcontroller timer sets the duration and repetition rate of two equal-duration pulse phases, and a regulated current driver sets their amplitude. A switching bridge reverses the polarity across the electrode pair for the second phase.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2011/0093026 A1
Published
Apr 21, 2011
Filed
Sep 28, 2010
Class
A61N 1/00
Document BUS 2014/0046397 A1
Published
Feb 13, 2014
Filed
Aug 7, 2013
Class
A61N 1/36007
Claim 1
Document A
Document B
1.1an electrode substrate having a first end and a second end, wherein the electrode substrate includes one or more electrodes on the electrode substrate, wherein the one or more electrodes are configured to apply electrical-stimulation therapy to an eye of a patient, the eye having an upper eyelid and a lower eyelid, wherein the electrode substrate is configured to locate the one or more electrodes on an outer surface of at least one of the upper eyelid and the lower eyelid of the patient’s eye;
Lead 108 includes a proximal end portion 121 configured to be connected to header 132, a distal end portion 123 including one or more electrodes for delivering cardiac stimulation pulses and/or sensing one or more physiological signals, and an elongate lead body 122 coupling between proximal end portion 121 and distal end portion 123.
A · US 2011/0093026 A1 · ¶ 25
Distal end 24b of lead 24 may be implanted adjacent to nerves 18 associated with bladder 12 (e.g., sacral nerves). Disposed generally near distal end 24b of lead 24 are a plurality of electrodes 26a-26d.
B · US 2014/0046397 A1 · ¶ 36
1.2a plurality of adhesive pads coupled to the electrode substrate and configured to secure the electrode substrate to the patient, wherein the plurality of adhesive pads includes a first adhesive pad and a second adhesive pad, wherein the first adhesive pad is located at the first end of the electrode substrate and is configured to couple to a first location on the patient, wherein the second adhesive pad is located between the first end and the second end of the electrode substrate and is configured to couple to a second location on the patient, and wherein the one or more electrodes are located on the electrode substrate between the first adhesive pad and the second adhesive pad; and
1.3a stimulation controller configured to control the electrical-stimulation therapy, wherein each of the one or more electrodes of the electrode substrate is operatively coupled to the stimulation controller.
The system of claim 6, wherein the one or more transvenous renal stimulation leads each comprise a plurality of electrodes incorporated into the one or more anchoring structures, and the stimulation control circuit is programmed to select one or more electrodes of the plurality of electrodes for delivering the renal stimulation pulses.
A · US 2011/0093026 A1 · claim 9
The system may further include a controller in communication with the stimulator device. The controller may have a processor configured to (i) cause a selected subset of the set of electrodes to deliver at least one electrical stimulation pulse and (ii) record at least one parameter of the electrical stimulation pulse delivered by the selected subset of electrodes after receiving patient feedback.
B · US 2014/0046397 A1 · ¶ 12

An empty cell means only that no passage was reproduced there.

Statements in these documents
Thus, there is a need for an efficient method and system for prompt treatment of decompensation in a heart failure patient.
A · US 2011/0093026 A1 · ¶ 4
The cardiorenal stimulation includes delivering renal electrical stimulation pulses to promote diuresis and/or natriuresis and delivering cardiac electrical stimulation pulses to enhance the diuretic and/or natriuretic effects of the renal electrical stimulation pulses.
A · US 2011/0093026 A1 · ¶ 5
While existing neuromodulation systems for treating overactive bladder syndrome may be effective for their intended purpose, it is desirable to improve methods of using such systems so that they may adjust for efficacy and patient tolerance levels to the electrical stimulation.
B · US 2014/0046397 A1 · ¶ 6
Additionally and/or alternatively, it is desirable to provide a system that may be intuitive to use so that it may be used by patients in an outpatient setting with limited or no medical supervision.
B · US 2014/0046397 A1 · ¶ 6
Cite aspatent.fyi, US 2026/0355504 A1, claim 1, first published 2026-11-19T12:21:55-05:00, https://patent.fyi/US20260355504/, SHA-256 d88e1f5f33b4d699a727b4c931f18fd8fe34699f21df3ac5ec8eea8075c01af8
First published
Permanent addresshttps://patent.fyi/US20260355504/
Content fingerprint (SHA-256)d88e1f5f33b4d699a727b4c931f18fd8fe34699f21df3ac5ec8eea8075c01af8
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi